IBDEI04X ; ; 06-AUG-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 06, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6318,0)
 ;;=272.2^^51^449^101
 ;;^UTILITY(U,$J,358.3,6318,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6318,1,3,0)
 ;;=3^Xanthelasma
 ;;^UTILITY(U,$J,358.3,6318,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,6318,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,6319,0)
 ;;=360.40^^51^449^60
 ;;^UTILITY(U,$J,358.3,6319,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6319,1,3,0)
 ;;=3^Globe/Eye Degenerative,Unspec
 ;;^UTILITY(U,$J,358.3,6319,1,4,0)
 ;;=4^360.40
 ;;^UTILITY(U,$J,358.3,6319,2)
 ;;=^268563
 ;;^UTILITY(U,$J,358.3,6320,0)
 ;;=360.42^^51^449^65
 ;;^UTILITY(U,$J,358.3,6320,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6320,1,3,0)
 ;;=3^Hypertensive Blind/Absolute Glaucoma
 ;;^UTILITY(U,$J,358.3,6320,1,4,0)
 ;;=4^360.42
 ;;^UTILITY(U,$J,358.3,6320,2)
 ;;=^268565
 ;;^UTILITY(U,$J,358.3,6321,0)
 ;;=360.89^^51^449^59
 ;;^UTILITY(U,$J,358.3,6321,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6321,1,3,0)
 ;;=3^Globe D/O,Other
 ;;^UTILITY(U,$J,358.3,6321,1,4,0)
 ;;=4^360.89
 ;;^UTILITY(U,$J,358.3,6321,2)
 ;;=^268581
 ;;^UTILITY(U,$J,358.3,6322,0)
 ;;=373.01^^51^449^5
 ;;^UTILITY(U,$J,358.3,6322,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6322,1,3,0)
 ;;=3^Blepharitis,Ulcerative
 ;;^UTILITY(U,$J,358.3,6322,1,4,0)
 ;;=4^373.01
 ;;^UTILITY(U,$J,358.3,6322,2)
 ;;=^269053
 ;;^UTILITY(U,$J,358.3,6323,0)
 ;;=373.31^^51^449^49
 ;;^UTILITY(U,$J,358.3,6323,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6323,1,3,0)
 ;;=3^Eyelid,Dermatitis,Eczematous
 ;;^UTILITY(U,$J,358.3,6323,1,4,0)
 ;;=4^373.31
 ;;^UTILITY(U,$J,358.3,6323,2)
 ;;=^269060
 ;;^UTILITY(U,$J,358.3,6324,0)
 ;;=373.34^^51^449^52
 ;;^UTILITY(U,$J,358.3,6324,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6324,1,3,0)
 ;;=3^Eyelid,Lupus Erythematosus,Discoid
 ;;^UTILITY(U,$J,358.3,6324,1,4,0)
 ;;=4^373.34
 ;;^UTILITY(U,$J,358.3,6324,2)
 ;;=^269064
 ;;^UTILITY(U,$J,358.3,6325,0)
 ;;=373.9^^51^449^37
 ;;^UTILITY(U,$J,358.3,6325,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6325,1,3,0)
 ;;=3^Eyelid Inflammation,NOS
 ;;^UTILITY(U,$J,358.3,6325,1,4,0)
 ;;=4^373.9
 ;;^UTILITY(U,$J,358.3,6325,2)
 ;;=^269070
 ;;^UTILITY(U,$J,358.3,6326,0)
 ;;=374.21^^51^449^75
 ;;^UTILITY(U,$J,358.3,6326,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6326,1,3,0)
 ;;=3^Lagophthalmos,Paralytic
 ;;^UTILITY(U,$J,358.3,6326,1,4,0)
 ;;=4^374.21
 ;;^UTILITY(U,$J,358.3,6326,2)
 ;;=^269091
 ;;^UTILITY(U,$J,358.3,6327,0)
 ;;=374.22^^51^449^74
 ;;^UTILITY(U,$J,358.3,6327,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6327,1,3,0)
 ;;=3^Lagophthalmos,Mechanical
 ;;^UTILITY(U,$J,358.3,6327,1,4,0)
 ;;=4^374.22
 ;;^UTILITY(U,$J,358.3,6327,2)
 ;;=^269093
 ;;^UTILITY(U,$J,358.3,6328,0)
 ;;=374.23^^51^449^73
 ;;^UTILITY(U,$J,358.3,6328,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6328,1,3,0)
 ;;=3^Lagophthalmos,Cicatricial
 ;;^UTILITY(U,$J,358.3,6328,1,4,0)
 ;;=4^374.23
 ;;^UTILITY(U,$J,358.3,6328,2)
 ;;=^269095
 ;;^UTILITY(U,$J,358.3,6329,0)
 ;;=374.31^^51^449^42
 ;;^UTILITY(U,$J,358.3,6329,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6329,1,3,0)
 ;;=3^Eyelid Ptosis,Paralytic
 ;;^UTILITY(U,$J,358.3,6329,1,4,0)
 ;;=4^374.31
 ;;^UTILITY(U,$J,358.3,6329,2)
 ;;=^269097
 ;;^UTILITY(U,$J,358.3,6330,0)
 ;;=374.32^^51^449^41
 ;;^UTILITY(U,$J,358.3,6330,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6330,1,3,0)
 ;;=3^Eyelid Ptosis,Myogenic
 ;;^UTILITY(U,$J,358.3,6330,1,4,0)
 ;;=4^374.32
 ;;^UTILITY(U,$J,358.3,6330,2)
 ;;=^269098
 ;;^UTILITY(U,$J,358.3,6331,0)
 ;;=374.33^^51^449^40
 ;;^UTILITY(U,$J,358.3,6331,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6331,1,3,0)
 ;;=3^Eyelid Ptosis,Mechanical
 ;;^UTILITY(U,$J,358.3,6331,1,4,0)
 ;;=4^374.33
 ;;^UTILITY(U,$J,358.3,6331,2)
 ;;=^269099
 ;;^UTILITY(U,$J,358.3,6332,0)
 ;;=374.34^^51^449^26
 ;;^UTILITY(U,$J,358.3,6332,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6332,1,3,0)
 ;;=3^Eyelid Blepharochalasis/Pseudoptosis
 ;;^UTILITY(U,$J,358.3,6332,1,4,0)
 ;;=4^374.34
 ;;^UTILITY(U,$J,358.3,6332,2)
 ;;=^15275
 ;;^UTILITY(U,$J,358.3,6333,0)
 ;;=374.41^^51^449^44
 ;;^UTILITY(U,$J,358.3,6333,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6333,1,3,0)
 ;;=3^Eyelid Retraction/Lag
 ;;^UTILITY(U,$J,358.3,6333,1,4,0)
 ;;=4^374.41
 ;;^UTILITY(U,$J,358.3,6333,2)
 ;;=^269101
 ;;^UTILITY(U,$J,358.3,6334,0)
 ;;=374.43^^51^449^25
 ;;^UTILITY(U,$J,358.3,6334,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6334,1,3,0)
 ;;=3^Eyelid Abn Innervation Synd
 ;;^UTILITY(U,$J,358.3,6334,1,4,0)
 ;;=4^374.43
 ;;^UTILITY(U,$J,358.3,6334,2)
 ;;=^269102
 ;;^UTILITY(U,$J,358.3,6335,0)
 ;;=374.46^^51^449^27
 ;;^UTILITY(U,$J,358.3,6335,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6335,1,3,0)
 ;;=3^Eyelid Blepharophimosis
 ;;^UTILITY(U,$J,358.3,6335,1,4,0)
 ;;=4^374.46
 ;;^UTILITY(U,$J,358.3,6335,2)
 ;;=^15279
 ;;^UTILITY(U,$J,358.3,6336,0)
 ;;=374.50^^51^449^30
 ;;^UTILITY(U,$J,358.3,6336,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6336,1,3,0)
 ;;=3^Eyelid Degen D/O,Unspec
 ;;^UTILITY(U,$J,358.3,6336,1,4,0)
 ;;=4^374.50
 ;;^UTILITY(U,$J,358.3,6336,2)
 ;;=^269106
 ;;^UTILITY(U,$J,358.3,6337,0)
 ;;=374.52^^51^449^34
 ;;^UTILITY(U,$J,358.3,6337,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6337,1,3,0)
 ;;=3^Eyelid Hyperpigmentation
 ;;^UTILITY(U,$J,358.3,6337,1,4,0)
 ;;=4^374.52
 ;;^UTILITY(U,$J,358.3,6337,2)
 ;;=^269108
 ;;^UTILITY(U,$J,358.3,6338,0)
 ;;=374.53^^51^449^36
 ;;^UTILITY(U,$J,358.3,6338,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6338,1,3,0)
 ;;=3^Eyelid Hypopigmentation
 ;;^UTILITY(U,$J,358.3,6338,1,4,0)
 ;;=4^374.53
 ;;^UTILITY(U,$J,358.3,6338,2)
 ;;=^269109
 ;;^UTILITY(U,$J,358.3,6339,0)
 ;;=374.54^^51^449^35
 ;;^UTILITY(U,$J,358.3,6339,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6339,1,3,0)
 ;;=3^Eyelid Hypertrichosis
 ;;^UTILITY(U,$J,358.3,6339,1,4,0)
 ;;=4^374.54
 ;;^UTILITY(U,$J,358.3,6339,2)
 ;;=^269111
 ;;^UTILITY(U,$J,358.3,6340,0)
 ;;=374.56^^51^449^39
 ;;^UTILITY(U,$J,358.3,6340,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6340,1,3,0)
 ;;=3^Eyelid Oth Degenerative Skin D/O
 ;;^UTILITY(U,$J,358.3,6340,1,4,0)
 ;;=4^374.56
 ;;^UTILITY(U,$J,358.3,6340,2)
 ;;=^269114
 ;;^UTILITY(U,$J,358.3,6341,0)
 ;;=374.81^^51^449^33
 ;;^UTILITY(U,$J,358.3,6341,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6341,1,3,0)
 ;;=3^Eyelid Hemorrhage
 ;;^UTILITY(U,$J,358.3,6341,1,4,0)
 ;;=4^374.81
 ;;^UTILITY(U,$J,358.3,6341,2)
 ;;=^269115
 ;;^UTILITY(U,$J,358.3,6342,0)
 ;;=374.82^^51^449^32
 ;;^UTILITY(U,$J,358.3,6342,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6342,1,3,0)
 ;;=3^Eyelid Edema
 ;;^UTILITY(U,$J,358.3,6342,1,4,0)
 ;;=4^374.82
 ;;^UTILITY(U,$J,358.3,6342,2)
 ;;=^276852
 ;;^UTILITY(U,$J,358.3,6343,0)
 ;;=374.85^^51^449^45
 ;;^UTILITY(U,$J,358.3,6343,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6343,1,3,0)
 ;;=3^Eyelid Vascular Anomalies
 ;;^UTILITY(U,$J,358.3,6343,1,4,0)
 ;;=4^374.85
 ;;^UTILITY(U,$J,358.3,6343,2)
 ;;=^269120
 ;;^UTILITY(U,$J,358.3,6344,0)
 ;;=374.86^^51^449^38
 ;;^UTILITY(U,$J,358.3,6344,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6344,1,3,0)
 ;;=3^Eyelid Oth D/O,Floppy Eyelid Synd
 ;;^UTILITY(U,$J,358.3,6344,1,4,0)
 ;;=4^374.86
 ;;^UTILITY(U,$J,358.3,6344,2)
 ;;=^269121
 ;;^UTILITY(U,$J,358.3,6345,0)
 ;;=376.11^^51^449^89
 ;;^UTILITY(U,$J,358.3,6345,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6345,1,3,0)
 ;;=3^Orbit Granuloma/Pseudotumor
 ;;^UTILITY(U,$J,358.3,6345,1,4,0)
 ;;=4^376.11
 ;;^UTILITY(U,$J,358.3,6345,2)
 ;;=^269176
 ;;^UTILITY(U,$J,358.3,6346,0)
 ;;=376.21^^51^449^93
 ;;^UTILITY(U,$J,358.3,6346,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6346,1,3,0)
 ;;=3^Orbit Thyrotoxic Exophthalmos
 ;;^UTILITY(U,$J,358.3,6346,1,4,0)
 ;;=4^376.21
 ;;^UTILITY(U,$J,358.3,6346,2)
 ;;=^269181
 ;;^UTILITY(U,$J,358.3,6347,0)
 ;;=376.33^^51^449^83
 ;;^UTILITY(U,$J,358.3,6347,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6347,1,3,0)
 ;;=3^Orbit Edema
 ;;^UTILITY(U,$J,358.3,6347,1,4,0)
 ;;=4^376.33
 ;;^UTILITY(U,$J,358.3,6347,2)
 ;;=^269186
 ;;^UTILITY(U,$J,358.3,6348,0)
 ;;=376.40^^51^449^82
 ;;^UTILITY(U,$J,358.3,6348,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6348,1,3,0)
 ;;=3^Orbit Deformity,Unspec
 ;;^UTILITY(U,$J,358.3,6348,1,4,0)
 ;;=4^376.40
 ;;^UTILITY(U,$J,358.3,6348,2)
 ;;=^269191
 ;;^UTILITY(U,$J,358.3,6349,0)
 ;;=376.41^^51^449^90
 ;;^UTILITY(U,$J,358.3,6349,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6349,1,3,0)
 ;;=3^Orbit Hypertelorism
 ;;^UTILITY(U,$J,358.3,6349,1,4,0)
 ;;=4^376.41
 ;;^UTILITY(U,$J,358.3,6349,2)
 ;;=^269192
 ;;^UTILITY(U,$J,358.3,6350,0)
 ;;=376.43^^51^449^81
 ;;^UTILITY(U,$J,358.3,6350,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6350,1,3,0)
 ;;=3^Orbit Deformity d/t Bone Disease
 ;;^UTILITY(U,$J,358.3,6350,1,4,0)
 ;;=4^376.43
 ;;^UTILITY(U,$J,358.3,6350,2)
 ;;=^269196
 ;;^UTILITY(U,$J,358.3,6351,0)
 ;;=376.44^^51^449^80
 ;;^UTILITY(U,$J,358.3,6351,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6351,1,3,0)
 ;;=3^Orbit Deform Assoc w/ Craniofac Deform
 ;;^UTILITY(U,$J,358.3,6351,1,4,0)
 ;;=4^376.44
 ;;^UTILITY(U,$J,358.3,6351,2)
 ;;=^269197
 ;;^UTILITY(U,$J,358.3,6352,0)
 ;;=376.51^^51^449^84
 ;;^UTILITY(U,$J,358.3,6352,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6352,1,3,0)
 ;;=3^Orbit Enophthalmos d/t Atroph Orb Tissue
 ;;^UTILITY(U,$J,358.3,6352,1,4,0)
 ;;=4^376.51
 ;;^UTILITY(U,$J,358.3,6352,2)
 ;;=^269204
 ;;^UTILITY(U,$J,358.3,6353,0)
 ;;=376.52^^51^449^85
 ;;^UTILITY(U,$J,358.3,6353,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6353,1,3,0)
 ;;=3^Orbit Enophthalmos d/t Trauma/Surg
 ;;^UTILITY(U,$J,358.3,6353,1,4,0)
 ;;=4^376.52
 ;;^UTILITY(U,$J,358.3,6353,2)
 ;;=^269205
 ;;^UTILITY(U,$J,358.3,6354,0)
 ;;=379.8^^51^449^96
 ;;^UTILITY(U,$J,358.3,6354,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6354,1,3,0)
 ;;=3^Ptosis Brow
 ;;^UTILITY(U,$J,358.3,6354,1,4,0)
 ;;=4^379.8
 ;;^UTILITY(U,$J,358.3,6354,2)
 ;;=^269332
 ;;^UTILITY(U,$J,358.3,6355,0)
 ;;=691.8^^51^449^10
 ;;^UTILITY(U,$J,358.3,6355,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6355,1,3,0)
 ;;=3^Dermatitis,Atopic
